Spedali Civili

Nov 26, 2024 | onlinelibrary.wiley.com | Matteo Pagnesi |Spedali Civili |Surgical Specialties |Marco Metra

Letter to the Editor Reply to ‘Malnutrition and severe heart failure in real-world study settings’ Matteo Pagnesi, Matteo Pagnesi Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy Search for more papers by this authorMarco Metra, Corresponding Author Marco Metra Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological...

Nov 14, 2024 | link.springer.com | Spedali Civili

AbstractAtopic dermatitis (AD) is a chronic, relapsing inflammatory skin condition that can have a negative impact on a patient’s quality of life. Long-term effectiveness is required to manage the symptoms of AD (skin inflammation, eczematous lesions, and itching).

Aug 21, 2024 | onlinelibrary.wiley.com | Jan Biegus |Gad Cotter |Marco Metra |Spedali Civili

Introduction Congestion is the most common clinical presentation and cause of admission for acute heart failure (AHF).1-3 Thus, effective decongestion has become a vital short-term goal for the treatment of AHF, as it can result in rapid improvement in the patient's symptoms and quality of life and shorter hospital stay.4 Achieving euvolaemia on hospital discharge is clinically relevant as is associated with better post-discharge outcomes; however, it remains challenging and is accomplished...

Jun 26, 2024 | academic.oup.com | Spedali Civili |Campus Benjamin Franklin

Cardiac sarcoidosis (CS) is a form of inflammatory cardiomyopathy associated with significant clinical complications such as high-degree atrioventricular block, ventricular tachycardia, and heart failure as well as sudden cardiac death. It is therefore important to provide an expert consensus statement summarizing the role of different available diagnostic tools and emphasizing the importance of a multidisciplinary approach.

Jun 23, 2024 | onlinelibrary.wiley.com | Riccardo M. Inciardi |Spedali Civili |Muthiah Vaduganathan |Carlo Lombardi

Introduction Heart failure (HF) represents a global health issue affecting more than 60 million people worldwide and leads the cause of hospitalization in both the United States and Europe.1 Despite the improvement in cardiovascular (CV) outcomes, patients with HF are yet exposed to an excess risk of hospitalization for HF and CV death.1, 2 Beta-blockers (BB), mineralocorticoid receptor antagonists (MRAs), angiotensin receptor–neprilysin inhibitor (ARNI) sacubitril/valsartan, and...